AI CuratorAI-generated
Research summary · AI summary · not yet reviewedHuman studyCase reportPeer review unconfirmed
Human Patient with Multiple Sclerosis on Natalizumab Experiences Vision Loss
A case report documented a patient with multiple sclerosis who was undergoing natalizumab therapy and experienced acute unilateral vision loss.
- Tags
- #MSResearch
- Most relevant to
- —
This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.
Why it matters
This case highlights the potential ocular complications that can arise in patients with MS receiving natalizumab therapy, emphasizing the need for careful monitoring.
What this does not prove
The findings from this case are based on a single patient report, and the evidence regarding treatment duration and routes of administration is limited and inconsistent.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Case report
- Participants / samples
- 1 · basis not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-09-29
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
Original sources
- Primary evidence[Acute unilateral loss of vision with retrobulbar pain in a patient with known multiple sclerosis-A clear diagnosis?]. ↗DOI: 10.1007/s00347-026-02528-3
Supporting passages (8)
study phaseIm vorliegenden Fall trat bei einem Patienten mit multipler Sklerose unter Natalizumab-Therapie ein akuter einseitiger Visusverlust auf.
study designIn this case report, a patient with multiple sclerosis undergoing natalizumab therapy experienced acute unilateral vision loss.
subjectsIm vorliegenden Fall trat bei einem Patienten mit multipler Sklerose unter Natalizumab-Therapie ein akuter einseitiger Visusverlust auf.
sample sizeIm vorliegenden Fall trat bei einem Patienten mit multipler Sklerose unter Natalizumab-Therapie ein akuter einseitiger Visusverlust auf.
publication datePublication date: 2026-09-29
interventionAntiviral therapy is indicated early on if acute retinal necrosis is clinically suspected.
findingsIn this case report, a patient with multiple sclerosis undergoing natalizumab therapy experienced acute unilateral vision loss.
limitationsThe evidence regarding treatment duration and routes of administration is currently limited and heterogeneous, necessitating an individualized treatment strategy tailored to clinical findings and immune status.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.